Farms.com Home   News

CGC Pleased With Harvest Sample Program Response

 
There's been a great response so far to this year's Harvest Sample Program being administered by the Canadian Grain Commission (CGC).
 
Chemist Twylla McKendry explains what they do with the information that is collected.
 
"The samples come in, the producers get their results back. They will get their grade, their protein, if there's any degrading factors in their sample. We then composite samples by grade and class and those samples are then milled, baked and we do a whole gamut of analytical testing. That information goes onto our website so buyers across the world can see what the current year's crop is like."
 
McKendry says so far this year they have collected over 14,000 samples of grain from across the country and have sent out about 9,300 results emails to farmers, which is a new service this year.
 
She notes the quality of this year's crop is much better than what it was in 2016. McKendry says in the Red Spring Wheat, 90 per cent of the crop is in the top two grades and farmers have been happy with yields. However, protein has been a concern, coming in at around 13 per cent.
 
Source : Steinbachonline

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.